Laser Treatments on Darker Skin: Why One Setting Doesn't Fit All
Sudha Mishra | Oct 29, 2026, 13:20 IST
Skin treatment
Most laser and energy-based devices were calibrated on lighter skin tones, and for Fitzpatrick Type IV and V patients, that gap is not a minor footnote, it determines whether a treatment works or causes lasting damage. Here is what the research gap means for your skin, and what to ask before anyone points a device at your face.
Highlights
- The majority of clinical trials for laser and energy-based devices have predominantly enrolled participants with Fitzpatrick skin types I to III, risking inadequate treatment for individuals with medium to dark-brown skin.
- Intense pulsed light devices and ablative fractional lasers carry significant risks for darker skin tones, including post-inflammatory hyperpigmentation and potential permanent hypopigmentation.
- Practitioners should be questioned about their experience treating Fitzpatrick Type IV and V skin, the appropriateness of the chosen device, and the inclusion of patch tests to ensure safe and effective treatment.
If you have medium-brown to dark-brown skin and you have ever sat in a consultation room while a technician adjusted settings that felt like an afterthought, your instinct was probably correct. The majority of pivotal trials for laser and energy-based devices enrolled predominantly Fitzpatrick Type I to III participants, fair to light-medium skin, and the settings approved as standard often reflect that sample, not yours.
Dermatologist Thomas Fitzpatrick developed his classification in 1975 to predict how skin responds to ultraviolet radiation, not to describe ethnicity. The scale runs from Type I, burns always, never tans, to Type VI, never burns, tans deeply. Types IV and V describe skin that tans easily and burns minimally, with higher baseline concentrations of melanin distributed throughout the epidermis and, in Type V, into the upper dermis.
That melanin concentration is the clinical variable that matters. Melanin absorbs light energy across a wide spectrum. When a device targets a chromophore, the pigment in a hair follicle, a blood vessel, or an unwanted tattoo pigment, the surrounding epidermal melanin competes for the same wavelength. In a Type II patient, that competition is modest. In a Type IV or V patient, it is substantial, and the risk of collateral thermal injury to the epidermis rises sharply if the operator does not account for it.
The three treatment categories that carry the most documented risk for darker skin tones are intense pulsed light, ablative fractional lasers, and Q-switched and picosecond lasers used for pigmentation.
Intense pulsed light devices emit a broad spectrum rather than a single wavelength. That broadband emission makes it difficult to target selectively, because epidermal melanin absorbs across much of the emitted range. At settings calibrated for lighter skin, IPL on Type IV or V skin can cause post-inflammatory hyperpigmentation, a darkening response triggered by thermal injury, or, less commonly, hypopigmentation, where melanocytes are damaged enough to stop producing pigment in a patch. Hypopigmentation on dark skin is visible, often permanent, and has no reliable treatment.
Ablative fractional lasers, such as fractional CO2 and erbium devices, resurface the skin by creating columns of thermal injury that stimulate repair. On lighter skin, the healing process tends to restore even tone. On Type IV and V skin, the inflammatory phase of healing is more likely to trigger post-inflammatory hyperpigmentation, sometimes lasting months. Extended downtime, mandatory sun avoidance, and a longer pre-treatment priming protocol, typically with a topical melanin-suppressant such as hydroquinone or azelaic acid, are standard requirements before ablative work on darker skin, not optional additions.
Q-switched and picosecond lasers target pigment by delivering energy in extremely short pulses that shatter pigment particles. They are used for tattoo removal and for conditions such as melasma and lentigines. The problem with melasma specifically is that it is a dermal and epidermal condition driven partly by hormonal signalling and sun exposure, not simply by excess pigment sitting in one place. Aggressive laser treatment of melasma on dark skin can paradoxically worsen it by triggering inflammation that re-stimulates melanocyte activity. Many dermatologists experienced in treating Type IV and V skin now approach melasma conservatively, reserving lasers for cases that have not responded to topical management and using the lowest effective fluence.
Not all energy-based treatments carry the same risk profile for darker skin. Radiofrequency devices, whether monopolar, bipolar, or microneedling RF, deliver energy through electrical resistance rather than light absorption. Because the mechanism does not depend on chromophore targeting, melanin concentration is not a competing variable. RF devices used for skin tightening, texture improvement, or collagen stimulation are generally considered safer across the Fitzpatrick range, provided the operator uses appropriate energy levels and does not over-treat.
Nd:YAG lasers operating at 1064 nm are the most widely recommended wavelength for hair removal on darker skin. At 1064 nm, the absorption differential between melanin and the target chromophore in the hair follicle is narrower than at shorter wavelengths like 755 nm alexandrite, which is poorly suited to Type IV and V skin. Even with Nd:YAG, longer pulse durations and adequate skin cooling are required to protect the epidermis. Multiple sessions remain necessary, typically six to eight, and results vary based on hair colour and coarseness.
Low-level laser therapy and LED-based devices operate at sub-thermal energy levels and do not carry the same thermal injury risk, though their evidence base for most cosmetic claims is weaker than for higher-energy devices.
The questions that matter are specific. Ask the practitioner what percentage of their treated patients have Fitzpatrick Type IV or V skin. Ask which laser or device they plan to use and why that wavelength is appropriate for your skin tone. Ask whether a patch test is included, and if not, why not, a patch test on an inconspicuous area four to six weeks before a full treatment is standard practice for darker skin and should not require negotiation. Ask what the protocol is if post-inflammatory hyperpigmentation develops.
If a practitioner cannot answer these questions fluently, or if the consultation does not include a Fitzpatrick assessment before device selection, that is a meaningful signal. The settings that work on the person who came before you may not be the settings that work on you, and on darker skin, the margin between an effective treatment and a visible injury is narrower than most marketing materials acknowledge.
The technology gap is real but it is not absolute. Practitioners who work regularly with South Asian, East African, and mixed-heritage patients develop the clinical experience to navigate it. That experience is worth seeking out before you book, not after.
Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!
What the Fitzpatrick Scale Actually Measures
That melanin concentration is the clinical variable that matters. Melanin absorbs light energy across a wide spectrum. When a device targets a chromophore, the pigment in a hair follicle, a blood vessel, or an unwanted tattoo pigment, the surrounding epidermal melanin competes for the same wavelength. In a Type II patient, that competition is modest. In a Type IV or V patient, it is substantial, and the risk of collateral thermal injury to the epidermis rises sharply if the operator does not account for it.
Where the Risk Is Highest and Why
Intense pulsed light devices emit a broad spectrum rather than a single wavelength. That broadband emission makes it difficult to target selectively, because epidermal melanin absorbs across much of the emitted range. At settings calibrated for lighter skin, IPL on Type IV or V skin can cause post-inflammatory hyperpigmentation, a darkening response triggered by thermal injury, or, less commonly, hypopigmentation, where melanocytes are damaged enough to stop producing pigment in a patch. Hypopigmentation on dark skin is visible, often permanent, and has no reliable treatment.
Ablative fractional lasers, such as fractional CO2 and erbium devices, resurface the skin by creating columns of thermal injury that stimulate repair. On lighter skin, the healing process tends to restore even tone. On Type IV and V skin, the inflammatory phase of healing is more likely to trigger post-inflammatory hyperpigmentation, sometimes lasting months. Extended downtime, mandatory sun avoidance, and a longer pre-treatment priming protocol, typically with a topical melanin-suppressant such as hydroquinone or azelaic acid, are standard requirements before ablative work on darker skin, not optional additions.
Q-switched and picosecond lasers target pigment by delivering energy in extremely short pulses that shatter pigment particles. They are used for tattoo removal and for conditions such as melasma and lentigines. The problem with melasma specifically is that it is a dermal and epidermal condition driven partly by hormonal signalling and sun exposure, not simply by excess pigment sitting in one place. Aggressive laser treatment of melasma on dark skin can paradoxically worsen it by triggering inflammation that re-stimulates melanocyte activity. Many dermatologists experienced in treating Type IV and V skin now approach melasma conservatively, reserving lasers for cases that have not responded to topical management and using the lowest effective fluence.
Devices That Carry Lower Risk at Appropriate Settings
Nd:YAG lasers operating at 1064 nm are the most widely recommended wavelength for hair removal on darker skin. At 1064 nm, the absorption differential between melanin and the target chromophore in the hair follicle is narrower than at shorter wavelengths like 755 nm alexandrite, which is poorly suited to Type IV and V skin. Even with Nd:YAG, longer pulse durations and adequate skin cooling are required to protect the epidermis. Multiple sessions remain necessary, typically six to eight, and results vary based on hair colour and coarseness.
Low-level laser therapy and LED-based devices operate at sub-thermal energy levels and do not carry the same thermal injury risk, though their evidence base for most cosmetic claims is weaker than for higher-energy devices.
What to Ask Before Your Consultation Goes Further
If a practitioner cannot answer these questions fluently, or if the consultation does not include a Fitzpatrick assessment before device selection, that is a meaningful signal. The settings that work on the person who came before you may not be the settings that work on you, and on darker skin, the margin between an effective treatment and a visible injury is narrower than most marketing materials acknowledge.
The technology gap is real but it is not absolute. Practitioners who work regularly with South Asian, East African, and mixed-heritage patients develop the clinical experience to navigate it. That experience is worth seeking out before you book, not after.
Discover expert advice and the latest updates in Skin Care, Hair Care, Wellness, Dermatology, and more at Stay Young guide to lasting beauty and holistic health!